Reaction Details |
| Report a problem with these data |
Target | Plasminogen |
---|
Ligand | BDBM588053 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Activities on Plasmin (Boc-QAR-AMC) |
---|
Ki | 14400±n/a nM |
---|
Citation | El Amri, C; Soualmia, F; Masurier, N; Aït Amiri, S; Nait Oumesmar, B; Deboux, C Compounds and compositions for the treatment of neurodegenerative and inflammatory diseases US Patent US11541023 Publication Date 1/3/2023 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Plasminogen |
---|
Name: | Plasminogen |
Synonyms: | Activation peptide | Angiostatin | PLG | PLMN_HUMAN | Plasmin | Plasmin heavy chain A | Plasmin heavy chain A, short form | Plasmin light chain B |
Type: | Enzyme |
Mol. Mass.: | 90579.18 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 810 |
Sequence: | MEHKEVVLLLLLFLKSGQGEPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFT
CRAFQYHSKEQQCVIMAENRKSSIIIRMRDVVLFEKKVYLSECKTGNGKNYRGTMSKTKN
GITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILE
CEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRE
LRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWS
AQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNSQVRWEYCKIPSCDSSPVSTE
QLAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAG
LTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPDVETPSEED
CMFGNGKGYRGKRATTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGG
PWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRT
RFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLE
PTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQ
LPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSW
GLGCARPNKPGVYVRVSRFVTWIEGVMRNN
|
|
|
BDBM588053 |
---|
n/a |
---|
Name | BDBM588053 |
Synonyms: | US11541023, Compound 1 |
Type | Small organic molecule |
Emp. Form. | C18H22N2O2 |
Mol. Mass. | 298.3795 |
SMILES | CC(C)(C)c1ccc(O)c(c1)C(=O)Nc1ccc(CN)cc1 |
Structure |
|